Volagidemab
- Generic Name
- Volagidemab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1233956-13-2
- Unique Ingredient Identifier
- 77JYS6UZ0M
- Background
Volagidemab is under investigation in clinical trial NCT03117998 (Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus).
- Associated Conditions
- -
- Associated Therapies
- -
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 24
- Registration Number
- NCT05696366
- Locations
- 🇺🇸
UC San Diego Altman Clinical & Translational Research Institute, La Jolla, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath